Brief: Regulatory Approval Clears Path For Oncolytics Biotech® To Advance Promising Pancreatic Cancer Treatment

Oncolytics Biotech

15/01/2025 12:22

Jan 15 (Reuters) - Oncolytics Biotech Inc  ONC.TO :
    * REGULATORY APPROVAL CLEARS PATH FOR ONCOLYTICS BIOTECH® TO
ADVANCE PROMISING PANCREATIC CANCER TREATMENT, FOLLOWING A
REVIEW OF SAFETY DATA
    * GERMANY'S MEDICAL REGULATORY BODY, PAUL-EHRLICH-INSTITUTE
APPROVED CONTINUATION OF PATIENT ENROLLMENT TO COHORT 5 OF
GOBLET STUDY

Source text:  ID:nPn5dsnyJa 
Further company coverage:  ONC.TO 

 ((Reuters.Briefs@thomsonreuters.com;))